No Deterioration in Glycemic Control in HNF-1 α Maturity-Onset Diabetes of the Young Following Transfer From Long-Term Insulin to Sulphonylureas [6]

Diabetes Care

Volumn 26, Issue 11, 2003, Pages 3191-3192

  Shepherd, Maggie ^a   Pearson, Ewan R ^a   Houghton, Jane ^b   Salt, Gill ^c   Ellard, Sian ^a   Hattersley, Andrew T ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

^b ROYAL PRESTON HOSPITAL   (United Kingdom)

^c NEW CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLICLAZIDE; HEMOGLOBIN A1C; INSULIN; NUCLEAR FACTOR I; NUCLEAR FACTOR IALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KETONURIA; LETTER; MATURITY ONSET DIABETES MELLITUS; UNITED KINGDOM;

EID: 0242363725     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.11.3191-a     Document Type: Letter

References (10)

1. Lambert AP, Ellard S, Allen LI, Gallen IW, Gillespie KM, Bingley P, Hattersley AT: Identifying hepatic nuclear factor 1α mutations in children and young adults with a clinical diagnosis of type 1 diabetes. Diabetes Care 26:333-337, 2003
2. Hathout EH, Cockburn BN, Mace JW, Sharkney J, Chen-Daniel J, Bell GI: A case of hepatocyte nuclear factor-1α diabetes/MODY 3 masquerading as type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulphonylurea (Letter) Diabetes Care 22:867-868, 1999
3. Lehto M, Tuomi T, Mahtani MM, Widen E, Forsblom C, Sarelin L, Gullstrom M, Isomaa B, Lehtovirta M, Hyrkko A, Kanninen T, Orho M, Manley S, Turner RC, Brettin T, Kirby A, Thomas J, Duyk G, Lander E, Taskinen MR, Groop L: Characterization of the MODY 3 phenotype: early-onset diabetes caused by an insulin secretion defect. J Clin Invest 99:582-591, 1997
4. Moller AM, Dalgaard LT, Pociot F, Nerup J, Hansen T, Pedersen O: Mutations in the hepatocyte nuclear factor-1 alpha gene in Caucasian families originally classified as having type 1 diabetes. Diabetologia 41:1528-1531, 1998
5. McCarthy M, Hatterstey AT: Molecular diagnostics in monogenic and multifactorial forms of type 2 diabetes. Expert Rev Mol Diagn 1:403-412, 2001
6. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Hattersley AT: Genetic aetiology of hyperglycaemia determines response to treatment in diabetes. Lancet. In press
7. Hattersley AT: Maturity-onset diabetes of the young: clinical heterogeneity explained by genetic heterogeneity. Diabet Med 15:15-24, 1998
8. Pearson ER, Velho G, Clark P, Stride A, Shepherd M, Frayling TM, Bulman MP, Ellard S, Froguel P, Hattersley AT: β-Cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1α and glucokinase mutations. Diabetes 50 (Suppl. 1): S101-S107, 2001
9. Shepherd M, Stride A, Ellard S, Mattersley AT: The MODY Link Nurse Project: integrating genetics into diabetes care, a new role for diabetes specialist nu rses. J Diabetes Nursing. In press
10. Tack CJJ, Ellard S, Hattersley AT: A severe clinical phenotype results from the co-inheritance of type 2 susceptibility genes and a hepatocyte nuclear factor-1α mutation (Letter). Diabetes Care 23:424-425, 2000